| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900 La Plata, Argentina
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
(Received 9 September 2004;
accepted after revision 21 October 2004;
first published online 4 November 2004)
Corresponding author A. Mattiazzi: Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60 y 120, 1900 La Plata, Argentina. Email: ramattia{at}atlas.med.unlp.edu.ar
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The aim of the present study was to re-explore the mechanisms of FDAR using two different approaches. First, since the main mechanism of the isoprenaline-dependent acceleration of relaxation (IDAR) is the increase in PLN phosphorylation residues (Lindemann et al. 1983; Vittone et al. 1990; Mundiña-Weilenmann et al. 1996; Said et al. 2002), we aimed to compare the degree of PLN phosphorylation residues for a similar FDAR and IDAR. Second, we also aimed to compare the time course of the development of FDAR and IDAR with that of Ser16 and Thr17 phosphorylation of PLN. To these purposes three different preparations were used: isolated perfused rat hearts; cat papillary muscles; and cat myocytes. The different preparations allowed us to sweep over a wide range of frequencies, in species with either positive or negative force–frequency relationships, as well as to explore the FDAR under isometric (or isovolumic) and isotonic conditions.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mechanical studies
Rat heart perfusion. Isolated rat hearts were perfused according to the Langendorff technique at constant temperature (37°C) and flow (12–14 ml min–1), as previously described (Mundiña-Weilenmann et al. 1996; Vittone et al. 1998). The composition of the physiological salt solution (PSS) was (mM): 128.3 NaCl, 4.7 KCl, 1.35 CaCl2, 20.2 NaHCO3, 0.4 NaH2PO4, 1.1 MgCl2, 11.1 glucose and 0.04 Na2EDTA; this solution was equilibrated with 95% O2–5% CO2 to give a pH of 7.4. To prevent interference from atrial beats on the electrical pacing, total heart blockade was performed by crushing the atrial septum. After this blockade, hearts were paced at different frequencies (Results). The mechanical activity of the heart was assessed by passing into the left ventricle a latex balloon connected to a pressure transducer (Perceptor DT, Namic, Glen Falls, NY, USA). The balloon was filled with aqueous solution to achieve a left ventricular end-diastolic pressure of approximately 10 mmHg.
Cat papillary muscles. One or two papillary muscles were dissected from the right ventricle of a cat heart and mounted vertically in a chamber to contract isometrically. The muscles were stretched until they reached the length at which maximal developed tension (DT) occurred and then allowed to stabilize for 1 h at a constant frequency (30 pulses min–1) and temperature (30°C) as previously described (Pedroni et al. 1990; Salas et al. 2001). Muscles were superfused with the same PSS as described above.
Isolation of cat myocytes. Myocytes were isolated according to the technique previously described (Vila-Petroff et al. 2003). Briefly, excised cat hearts were mounted on a Langendorff perfusion apparatus. For enzymatic cell isolation, 118 units ml–1 collagenase type B (Worthington Biochemical Corp., Lakewood, NJ, USA) and 0.1 mg ml–1 pronase (Boerhinger Mannheim Corp., GmbH, Mannheim, Germany), were used. Perfusion solutions were similar to the PSS buffer described above, except that bicarbonate was replaced by 10 mM Hepes, pH adjusted to 7.4 (with NaOH) and the solution was continuously equilibrated with 100% O2. The concentration of Ca2+ varied along the different steps in the isolation procedure. After enzymatic treatment, disaggregated myocytes were separated from the undigested tissue, rinsed several times with a Hepes solution containing 1% BSA and 500 µM CaCl2 and kept in this solution at room temperature until use. Rod-shaped myocytes with clear and distinct striations and an obvious marked shortening and relaxation on stimulation were used. The experiments were performed at room temperature.
Indo-1 fluorescence and cell shortening measurements. Isolated myocytes were loaded with the cell-permeant acetomethyl ester form of indo-1 (17 µM for 9 min) according to the bulk method described by Spurgeon et al. (1990) and as we previously described (Vila-Petroff et al. 2003). Cells were placed on the stage of an inverted microscope (Nikon Diaphot 200) adapted for epifluorescence. Myocytes were continuously superfused at a constant flow (1 ml min–1) and field stimulated via two platinum electrodes on either side of the bath (square waves, 2 ms duration and 20% above threshold). The excitation light was centred at 350 nm and the fluorescence emitted by the cell was recorded at 410 and 482 nm. Background fluorescence was subtracted from each signal before obtaining the 410:482 fluorescence ratio. Diastolic fluorescence ratio was measured as the mean value over a 100 ms period after the twitch was completed. Systolic fluorescence ratio was determined directly from the peak of the recorded ratio. Resting cell length and cell shortening were measured by a video-based motion detector (Crescent Electronics, Sandy, UT, USA) and stored by software for an off-line analysis. For phosphorylation studies an aliquot of the isolated myocyte suspension was placed on the stage of an optical microscope and field stimulated at room temperature. Laemmli sample buffer was added to terminate the experiment.
Biochemical assays
Preparation of rat heart SR membranes. Rat SR membrane vesicles were prepared as previously described (Mundiña-Weilenmann et al. 1996). Briefly, the pulverized ventricular tissue was homogenized in six volumes of homogenization buffer containing (mM): 5 Na2EDTA, 25 NaF, 300 sucrose, 1 phenylmethanesulphonyl fluoride (PMSF), 1 benzamidine and 30 KH2PO4. The homogenate was centrifuged twice at 14 000 and 16 000g for 20 min. The resulting supernatant was centrifuged at 45 000g for 45 min. The pellet obtained was suspended in three volumes of buffer containing (mM): 10 Na2EDTA, 25 NaF, 600 KCl, and 50 KH2PO4, and re-centrifuged as in the previous step. The resulting pellet was suspended in 10 mM Na2EDTA, 10 mM NaF, 250 mM sucrose and 30 mM histidine.
Papillary muscles. Papillary muscles, pooled to get approximately 20 mg, were homogenized in 250 µl of a buffer containing (mM): 50 Na4P2O7, 50 NaF, 50 NaCl, 5 Na2EDTA, 5 EGTA, 0.1 Na3VO4, 10 Hepes, 1 PMSF, 1 benzamidine and 0.5 µg ml–1 N-(trans-epoxysuccinyl)-L-leucine 4-guanidinobutylamide (E-64), with a Teflon pestle and centrifuged at 11 500g for 20 min at 4°C. The supernatant was used for phosphorylation studies.
Solutions in the homogenization and membrane isolation procedure were pH 7.0 at 4°C. In all preparations, protein concentration was measured by the method of Bradford using bovine serum albumin as standard.
Electrophoresis and Western blot analysis. For immunological detection of PLN phosphorylation sites, 20–30 µg of SR membrane proteins, homogenized papillary muscles or myocyte suspension were electrophoresed per gel lane in a 10% SDS polyacrylamide gel, as previously described (Mundiña-Weilenmann et al. 1996). Proteins were then transferred to Immobilon-P polyvinylidene difluoride (PVDF) membranes and probed with the phosphorylation site-specific phosphorylated PSer16 and PThr17 PLN antibodies (1:5000; Badrilla, Leeds, UK). Immunoreactivity was visualized by peroxidase-conjugated antibodies using a peroxidase-based chemiluminescence detection kit (Amersham Bioscience). The signal intensity of the bands on the film was quantified using Scion Image software (based on NIH Image). Unless otherwise indicated, phosphorylation results are expressed as percentage of maximal Ser16 and Thr17 phosphorylation induced by isoprenaline, run in parallel. In additional experiments, 50 µg of SR membranes proteins were resolved in 8% acrylamide gels according to Laemmli. Proteins were transferred and probed with antiserum specific antibody for the Ca2+-ATPase peptide phosphorylated on Ser38, SERCA PS-38 (1:5000). As a positive standard, 0.1–2 pmol of a peptide containing the phosphorylated Ser38 site of SERCA2a, constructed as described by Rodriguez et al. (2004), was used. Both the antibody and the phosphopeptide were kindly provided by J. Colyer (University of Leeds, UK). Immunoreactivity was visualized as described above.
Back phosphorylation.
Thirty micrograms of SR membranes, isolated as described above from hearts submitted to different frequencies, were phosphorylated in 50 µl of a reaction medium containing 50 mM Hepes (pH 7.4), 10 mM MgCl2, 0.1 mM EGTA, 2 µM calmodulin and 0.1 mM CaCl2. The reaction was initiated by the addition of 50 µM
[
-32P]ATP, specific activity 1000–1600 counts min–1 pmol–1, following preincubation of the rest of the assay components for 3 min at 30°C. The reaction was terminated after 5 min by the addition of SDS sample buffer, and the samples were subjected to SDS-PAGE in a 5–15% gradient gel. The gels were stained with Comassie Blue, dried and autoradiographed. 32Phosphorus incorporation into the specific bands was quantified by analysing the signal intensity of the bands as described for the Western blot. Phosphorylation results were expressed as a percentage of the signal obtained at 120 beats min–1.
Statistics
Data are expressed as means ± S.E.M. Statistical significance was determined by Student's t test for paired and unpaired observations, as appropriate. A P value < 0.05 was considered statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Several previous studies indicate that the SR is involved in the relaxant effect of increasing contraction frequency (FDAR; Schouten, 1990; Bassani et al. 1995; Hussain et al. 1997). Experiments were performed to confirm this issue in our experimental conditions. Figure 1 shows typical records of the left ventricular developed pressure (LVDP) of a perfused rat heart. The increase in contraction frequency from 60 to 120 beats min–1 decreased LVDP (negative staircase, Fig. 1A). This negative inotropic effect was associated with a FDAR, which is better appreciated in the normalized records of Fig. 1B. Perfusion with ryanodine and thapsigargin, to functionally block the SR, abolished the FDAR as shown in the original and normalized records of Fig. 1C and D, respectively. The low range of the force–frequency relationship explored in these experiments was due to the fact that higher, more physiological frequencies for the rat, cause contracture of the hearts in the absence of a functional SR. As an additional index of FDAR, we used the ratio between the half-relaxation time (t
) at the high and the low frequency studied (t at 120 beats min–1/t at 60 beats min–1; Fig. 1E; De Santiago et al. 2002). A significant decrease of this index below a ratio of 1 is indicative of FDAR. It can be seen that in the absence of ryanodine and thapsigargin, the increase in the stimulation frequency reduced the FDAR index to 0.86 ± 0.04, n
= 4
(P < 0.05), whereas in the presence of these drugs, FDAR was abolished. Thus, it seems undoubted that the underlying mechanism of FDAR either resides at the SR level or at least needs a functionally intact SR.
|
Figure 2 illustrates the relaxant effect and the average PLN phosphorylation at Ser16 and Thr17 sites, observed with incremental heart rates (Fig. 2A) and isoprenaline concentrations (Fig. 2B) in the perfused rat heart. Both the FDAR and the isoprenaline-dependent acceleration of relaxation (IDAR) were similar, as indicated by the reduction of t. However, while increasing stimulation frequency from 120 to 510 beats min–1 failed to increase the phosphorylation of Ser16 and Thr17 of PLN, addition of isoprenaline from 0.3 to 300 nM produced a significant increase in the phosphorylation of both PLN residues. Similar results were obtained in another multicellular preparation of a different species, the cat papillary muscle. Again, while the relaxant effect of 1 µM isoprenaline was associated with a significant increase in the phosphorylation of Ser16 and Thr17 residues of PLN, no significant changes in the phosphorylation of both residues were observed, for a similar relaxant effect produced by raising stimulation frequency from 10 to 60 beats min–1 (Fig. 3).
|
|
. However, both curves were parallel and the FDAR index did not reveal any differences between the values measured in the absence and the presence of the ß-agonist (t at 510 beats min–1/t at 120 beats min–1
= 0.59 ± 0.02 and 0.54 ± 0.06, respectively, Fig. 4B). We next tested the variation of heart rate at a maximal isoprenaline stimulation (300 nM, Fig. 4C). At this maximal concentration, stimulation frequency was increased from 120 to 590 beats min–1. At a fixed stimulation frequency of 120 beats min–1, isoprenaline produced a concentration-dependent increase in the relaxant effect. At a maximal isoprenaline concentration (300 nM), an abrupt change to 510 beats min–1 in the continuous presence of the ß-agonist produced a further decrease in t that was not associated with any additional increase in the phosphorylation of PLN sites (Fig. 4D).
|
Is SERCA2a the target of the CaMKII activation induced by increasing stimulation frequency responsible of FDAR?
The results presented so far are compelling evidence indicating the lack of any important physiological role of PLN in the FDAR phenomenon. To test the possible participation of other CaMKII substrates in the FDAR, the status of phosphorylation of SERCA2a, the major alternative candidate, was explored. Figure 5A shows a typical autoradiogram and overall results of the phosphorylation of SERCA2a, studied by the back phosphorylation technique in perfused rat hearts, at two different stimulation frequencies, 120 and 510 beats min–1. The back phosphorylation method shows the mirror phosphorylation image of the actual in vivo phosphorylation. Phosphorylation of SERCA2a was the same at the two frequencies explored. Moreover, and in agreement with the experiments performed with site-specific phosphorylation antibodies (Fig. 2A), no significant changes in the phosphorylation of PLN were observed. Similar results were obtained in the presence and absence of added exogenous CaMKII, which would indicate that possible variations in the CaMKII activity in the different experimental situations are not responsible for the results obtained. In an additional group of experiments, we used a recently described polyclonal antibody specific for the phosphorylated Ser38 peptide of SERCA2a (Rodriguez et al. 2004) to evaluate the phosphorylation of SERCA2a in SR membrane vesicles isolated from hearts contracting at 120 and 510 beats min–1. The immunoblot of Fig. 5B shows that no significant phosphorylation of SERCA2a could be detected in these membrane preparations, in spite of the high immunodetection sensitivity of the assay (0.5 pmol of the phosphopeptide used for calibration, see Methods). Assuming that SERCA2a is 10% of total SR protein (Hawkins et al. 1994), 50 pmol SERCA2a should be expected in 50 µg of SR protein loaded per gel lane. The lack of detection of SERCA2a phosphorylation would indicate that, if phosphorylation occurred, it would result in the generation of less than 1% of Ser38 phosphoprotein.
|
In a further attempt to study the possible involvement of the CaMKII-dependent phosphorylations in the FDAR, we performed experiments with the specific CaMKII inhibitor, KN-93. Since KN-93 is unable to inhibit the autophosphorylated form of CaMKII (Tokumitsu et al. 1990), hearts were perfused with 5 µM of the inhibitor in the presence of low extracellular Ca2+ (0.25 mM) for 10 min, to diminish Ca2+ entry to the cell and allow for dephosphorylation of the enzyme (Bassani et al. 1995). Increasing the stimulation frequency from 120 to 510 beats min–1 decreased t by 20.10 ± 2.83 ms and the time constant of the Ca2+ transient decay (
) by 7.40 ± 2.52 ms (n
= 5) in the absence of KN-93. In the presence of the inhibitor, t and decreased by 17.60 ± 3.31 and 5.10 ± 4.11 ms, respectively (n
= 5). Of note, despite the lack of effect of KN-93 on relaxation, the CaMKII inhibitor produced a significant enhancement of the negative staircase observed in the perfused rat heart. Raising the stimulation frequency from 120 to 510 beats min–1 diminished LVDP by 38.83 ± 2.39 and 76.28 ± 2.93% in the absence and presence, respectively, of KN-93. This negative inotropic effect may be the consequence of KN-93 inhibition of L-type Ca2+ current (especially at higher frequencies), or ryanodyne receptor gating (Li et al. 1997). These results indicate that the failure of KN-93 to significantly impair FDAR is not due to either an inadequate concentration of KN-93 or to the protocol of administration of the inhibitor.
Phosphorylation of Thr17 of PLN in myocytes
The lack of detection of any significant increase in PLN phosphorylation after increasing the stimulation frequency in multicellular preparations is hard to reconcile with the findings of Hagemann et al. (2000), who reported a close association between FDAR and the phosphorylation of Thr17 of PLN in isolated rat myocytes. To examine whether the cause of the discrepant results resides in the different preparations used, we performed experiments in isolated cat myocytes. Stimulation frequencies ranging from 10 to 60 beats min–1 produced an FDAR, indexed by the decrease in the time from the peak to half of the Ca2+ transient decline (t transient), and a significant increase in the phosphorylation of Thr17 at faster stimulation rates, independently of that of Ser16 (Fig. 6A). Figure 6B shows that the frequency-dependent abbreviation of the t transient tightly correlates with the frequency-dependent increase in Thr17 phosphorylation. However, when the degree of PLN phosphorylation obtained at the maximal FDAR was compared with the isoprenaline-induced PLN phosphorylation at a similar relaxant effect, the latter intervention (3 nM isoprenaline) significantly enhanced the phosphorylation of both PLN residues (49.1 ± 7.8 and 56.6 ± 16.6%, n
= 7, above basal values for Ser16 and Thr17, respectively), whereas the increase in stimulation frequency only enhanced the phosphorylation of Thr17 site by 29.6 ± 7.2%, n
= 9, without modifications in the phosphorylation of Ser16 (Fig. 7).
|
|
transient in myocytes, we studied the time course of the appearance of the FDAR and Thr17 phosphorylation (Fig. 8A). As early as in the second beat (2.5 s) after the frequency step (from 10 to 50 beats min–1), the t transient was significantly decreased, reaching its lowest value. However, phosphorylation of PLN at the Thr17 residue significantly increased 15 s after the frequency change. Thus, phosphorylation of Thr17 occurred at a slower rate than the FDAR, arguing against the participation of PLN phosphorylation in the determination of this effect. In contrast, the onset of IDAR was temporally associated with the increase in the phosphorylation of Ser16 (Fig. 8B). Phosphorylation of Thr17 became significant only after 2 min of isoprenaline administration (66.0 ± 15.3%). This increase was associated with a further enhancement of IDAR, which occurred in the absence of any significant increase in the phosphorylation of Ser16. The time-delayed Thr17 phosphorylation is consistent with former results in rat and guinea-pig hearts (Wegener et al. 1989; Kuschel et al. 1999) and might indicate that the PKA-dependent increase in intracellular Ca2+ is not large enough at the very beginning of isoprenaline administration to activate CaMKII (Said et al. 2002).
|
) and the time constant of the Ca2+ transient decay () associated with a frequency step from 10 to 50 beats min–1, was not different in the presence and in the absence of the CaMKII inhibitor. Another CaMKII inhibitor (autocamtide-2 related inhibitory peptide, AIP, 10 µM) also failed to diminish the relaxant effect of the increase in contraction frequency. Thus, even in a preparation in which the increase in stimulation frequency increases the phosphorylation of the Thr17 site of PLN, this phosphorylation cannot explain the FDAR.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Our major finding is that the phosphorylation of PLN residues does not participate in FDAR and that FDAR and IDAR should be explained by different mechanisms. While IDAR occurs closely associated with a significant increase in PLN phosphorylation, no significant increases in the phosphorylation of Thr17 residue of PLN, the site that would be expected to be phosphorylated by increasing stimulation frequency, could be detected associated with FDAR in the perfused rat heart and in cat papillary muscles (Figs 2 and 3). Furthermore, the increase in stimulation frequency produced a similar and parallel relaxant effect when hearts were perfused in the presence and the absence of a high isoprenaline concentration, without any significant increase in the level of PLN phosphorylation above the value observed at the lowest frequency (Fig. 4). Although FDAR was associated with an increase in Thr17 phosphorylation in isolated myocytes, this increase occurred after the maximal FDAR was reached (Fig. 8). In contrast, the increase in the phosphorylation of the Ser16 residue of PLN, the first site that becomes phosphorylated upon isoprenaline administration, was temporally associated with a relaxant effect. This relaxant effect was further enhanced when phosphorylation of Thr17 site attained significant levels. These results clearly indicate that FDAR is not dependent on the phosphorylation of Thr17, and that IDAR and FDAR do not share any common underlying mechanism. In addition, FDAR occurs in the absence of any detectable increase in SERCA2a phosphorylation (Fig. 5).
In the intact ventricle, activation of CaMKII and inhibition of PP1, the phosphatase that dephosphorylates PLN, have been shown to be necessary conditions for detection of the phosphorylation of Thr17 of PLN (Mundiña-Weilenmann et al. 1996; Vittone et al. 1998; Said et al. 2002). These prerequisites are achieved after ß-adrenoceptor stimulation, in which the activation of PKA increases intracellular calcium (by phosphorylation of the Ser16 residue of PLN and L-type Ca2+ channels; Tsien et al. 1986; Mundiña-Weilenmann et al. 1996) and inhibits PP1 (Cohen & Cohen, 1989; Gupta et al. 2002), or by mimicking these conditions by increasing extracellular calcium in the presence of either acidic pH or okadaic acid, to inhibit PP1 (Mundiña-Weilenmann et al. 1996; Vittone et al. 1998; Said et al. 2002). Indeed, we have previously shown that increasing extracellular calcium, which by itself failed to increase the phosphorylation of Thr17, significantly increased the phosphorylation of this residue in the presence of either high isoprenaline concentrations or phosphatase inhibitors (Mundiña-Weilenmann et al. 1996; Vittone et al. 1998; Said et al. 2002). In the present experiments, it was shown that the increase in stimulation frequency did not further increase the phosphorylation of Thr17, even in the presence of a high isoprenaline concentration. These results would indicate that the increase in contraction frequency either failed to enhance CaMKII activation above that evoked by isoprenaline or produced an increase in phosphatase activity that would counteract the ß-agonist-induced phosphatase inhibition. The latter possibility seems unlikely, however, since Ser16 phosphorylation was not decreased by the increase in stimulation frequency. In any case, our results demonstrated that the increase in frequency produced a pronounced and significant relaxant effect, under conditions in which the hearts already showed an accelerated relaxation owing to the presence of isoprenaline and in the absence of any significant change in Thr17 phosphorylation.
The present experiments also showed, however, that in isolated myocytes, FDAR was associated with an increase in Thr17 phosphorylation. This finding is in agreement with the experiments of Hagemann et al. (2000), which showed a good correlation between the phosphorylation of Thr17 and FDAR. However, a good correlation coefficient does not necessarily imply a causal relationship. We showed that the increase in PLN phosphorylation observed with FDAR, i.e. Ser16 and Thr17 sites, was significantly lower than that associated with IDAR, for the same relaxant effect. More importantly, the CaMKII-induced phosphorylation of the Thr17 site of PLN observed in the intact myocytes was temporally dissociated from the relaxant effect of increasing stimulation frequency. As further support for the lack of participation of Thr17 phosphorylation on FDAR, specific inhibition of CaMKII by KN-93 failed to affect FDAR. Thus, our results do not support the conclusion of Hagemann et al. (2000), in the sense that the relaxant effect of increasing stimulation frequency was determined by the degree of Thr17 phosphorylation.
The cause of the contradictory findings that Thr17 was phosphorylated by increasing stimulation frequency in isolated myocytes but not in the perfused rat heart or the papillary muscle is not apparent to us. The degree of phosphorylation of any protein depends on the balance between the activities of kinases and phosphatases involved in this particular phosphorylation. The increase in the phosphorylation of Thr17 of PLN in the isolated myocytes associated with FDAR, as opposed to the lack of phosphorylation in the intact heart and the papillary muscles, may indicate either a higher CaMKII activity or a lower phosphatase activity in the isolated myocytes compared with the multicellular preparations. Although we did not explore these possibilities, it is tempting to speculate that the lower temperature used in the experiments with isolated myocytes may produce a relatively higher inhibition of phosphatases than of CaMKII, leading to the necessary imbalance responsible for the increase in phosphorylation of Thr17 observed in isolated myocytes. Evidence suggesting a higher inactivation of phosphatases relative to kinases has been found in both intact and permeabilized rat myocytes (Mattiazzi et al. 1994; Bassani et al. 1995), working also at low temperature.
Experiments from Narayanan's group (Xu et al. 1993; Xu & Narayanan, 1999; 2000,) were the first to describe a direct CaMKII-dependent phosphorylation of SERCA2a. This phosphorylation, occurring at Ser38, resulted in activation of the Vmax of Ca2+ transport (Xu et al. 1993; Toyofuku et al. 1994; Xu & Narayanan, 1999). Other results, however, argue against this finding. While Reddy et al. (1996) failed to demonstrate a CaMKII-dependent phosphorylation of SERCA2a, Odermatt et al. (1996) did show a significant increase in Ser38 phosphorylation that was, however, not associated with any significant change in the activity of SERCA2a. The present experiments failed to demonstrate any significant increase in SERCA2a phosphorylation from increasing stimulation frequency. A possible source of error to be considered is that the lack of SERCA2a phosphorylation with increasing stimulation frequency might arise from the fact that the phosphorylation of a single residue in a huge protein, although present, cannot be detected with the method used. However, in agreement with previous findings (Rodriguez et al. 2004), phosphorylation of the Ser38 residue of SERCA2a was also undetected when using a sensitive specific antibody raised against this site. In addition, the fact that KN-93 failed to affect FDAR both in intact myocytes and perfused hearts would further support the contention that the CaMKII-dependent phosphorylation of SERCA2a is not involved in the FDAR.
The lack of dependence of FDAR on CaMKII shown in the present results is in agreement with previous findings (Hussain et al. 1997; Layland & Kentish, 1999; Kassiri et al. 2000). In contrast, other experiments were able to demonstrate a CaMKII dependence of FDAR (Bassani et al. 1995; Li et al. 1997, 1998; De Santiago et al. 2002). The cause of these opposite results is not readily apparent. The different experimental protocols (steady state versus post-rest contractions) used in some of these previous studies (Bassani et al. 1995; Li et al. 1997, 1998) could be partly responsible for the discrepant results. This issue, however, requires further investigation.
Kimura et al. (1997) first proposed that elevated Ca2+, by itself, enhances the PLN–SERCA2a heterodimer dissociation, thereby increasing SERCA2a activity. More recent experiments from the same group further showed that high Ca2+ disrupts the physical interaction between PLN and SERCA2a in HEK cells, overexpressing SERCA2a and PLN (Asahi et al. 2000). Although it is difficult to explore this model in vivo, it is tempting to speculate that FDAR can be explained by a direct effect of high intracellular Ca2+ on the interaction between PLN and SERCA2a, a possibility that does not require CaMKII activation.
In any case, our results provided direct evidence indicating that the FDAR phenomenon is not dependent on the phosphorylation of any of the two main proteins involved in the SR calcium uptake. The results show in addition that IDAR and FDAR do not share a common underlying mechanism.
|
Footnotes |
|---|
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Bassani RA, Mattiazzi A & Bers DM (1995). CaMKII is responsible for activity-dependent acceleration of relaxation in rat ventricular myocytes. Am J Physiol 268, H703–H712.[Medline]
Bers DM (2000). Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd edn. Kluwer Academic Publishers, The Netherlands.
Bluhm WF, Kranias EG, Dillmann WH & Meyer M (2000). Phospholamban: a major determinant of the cardiac force-frequency relationship. Am J Physiol 278, H249–H255.
Champion
HC, Georgakopoulos
D, Haldar
S, Wang
L, Wang
Y
&
Kass
DA (2003). Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology. Circulation
108, 2790–2797.
Cohen
P
&
Cohen
PT (1989). Protein phosphatases come of age. J Biol Chem
264, 21435–21438.
De Koninck
P
&
Schulman
H (1998). Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science
279, 227–230.
De Santiago J, Maier LS & Bers DM (2002). Frequency dependent acceleration of relaxation in the heart depends on CaMKII, but not phospholamban. J Mol Cell Cardiol 34, 975–984.[CrossRef][Medline]
Gupta RC, Neumann J, Watanabe AM & Sabbah HN (2002). Inhibition of type 1 protein phosphatase activity by activation of beta-adrenoceptors in ventricular myocardium. Biochem Pharmacol 63, 1069–1076.[CrossRef][Medline]
Hagemann
D, Kuschel
M, Kuramochi
T, Zhu
W, Cheng
H
&
Xiao
RP (2000). Frequency-encoding Thr17 phospholamban phosphorylation is independent of Ser16 phosphorylation in cardiac myocytes. J Biol Chem
275, 22532–22536.
Hawkins
C, Xu
A
&
Narayanan
N (1994). Sarcoplasmic reticulum calcium pump in cardiac and slow twitch skeletal muscle but not fast twitch skeletal muscle undergoes phosphorylation by endogenous and exogenous Ca2+/calmodulin-dependent protein kinase. Characterization of optimal conditions for calcium pump phosphorylation. J Biol Chem
269, 31198–31206.
Hussain M, Drago GA, Colyer J & Orchard CH (1997). Rate-dependent abbreviation of Ca2+ transient in rat heart is independent of phospholamban phosphorylation. Am J Physiol 273, H695–H706.[Medline]
Kassiri
Z, Myers
R, Kaprielian
R, Banijamali
HS
&
Backx
PH (2000). Rate-dependent changes of twitch force duration in rat cardiac trabeculae: a property of the contractile system. J Physiol
524, 221–231.
Kimura
Y, Kurzydlowski
K, Tada
M
&
MacLennan
DH (1997). Phospholamban inhibitory function is activated by depolymerization. J Biol Chem
272, 15061–15064.
Kuschel M, Karczewski P, Hempel P, Schlegel W-P, Krause E-G & Bartel S (1999). Ser16 prevails over Thr17 phospholamban phosphorylation in the ß-adrenergic regulation of cardiac relaxation. Am J Physiol 276, H1625–H1633.[Medline]
Layland J & Kentish JC (1999). Positive force- and [Ca2+]i-frequency relationships in rat ventricular trabeculae at physiological frequencies. Am J Physiol 276, H9–H18.[Medline]
Li L, Chu G, Kranias EG & Bers DM (1998). Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol 274, H1335–H1347.[Medline]
Li L, Satoh H, Ginsburg KS & Bers DM (1997). The effect of Ca2+–calmodulin-dependent protein kinase II on cardiac excitation–contraction coupling in ferret ventricular myocytes. J Physiol 501, 17–31.[CrossRef][Medline]
Lindemann
JP, Jones
LR, Hathaway
DR, Henry
BG
&
Watanabe
AM (1983). beta-Adrenergic stimulation of phospholamban phosphorylation and Ca2+ATPase activity in guinea pig ventricles. J Biol Chem
258, 464–471.
Mattiazzi A, Hove-Madsen L & Bers DM (1994). Protein kinase inhibitors reduce SR Ca transport in permeabilized cardiac myocytes. Am J Physiol 267, H812–H820.[Medline]
Mundiña-Weilenmann
C, Vittone
L, Ortale
M, Chiappe de Cingolani
G
&
Mattiazzi
A (1996). Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem
271, 33561–33567.
Odermatt
A, Kurzydlowski
K
&
MacLennan
DH (1996). The Vmax of the Ca2+-ATPase of cardiac sarcoplasmic reticulum (SERCA2a) is not altered by Ca2+/calmodulin-dependent phosphorylation or by interaction with phospholamban. J Biol Chem
271, 14206–14213.
Pedroni P, Perez GN & Mattiazzi A (1990). Calcium sensitivity of isometric tension in intact papillary muscles and chemically skinned trabeculae in different models of hypertensive hypertrophy. Cardiovasc Res 24, 584–590.[Medline]
Reddy
LG, Jones
LR, Pace
RC
&
Stokes
DL (1996). Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase. J Biol Chem
271, 14964–14970.
Rodriguez
P, Jackson
WA
&
Colyer
J (2004). Critical evaluation of cardiac Ca2+-ATPase phosphorylation on serine 38 using a phosphorylation site-specific antibody. J Biol Chem
279, 17111–17119.
Said M, Mundiña-Weilenmann C, Vittone L & Mattiazzi A (2002). The relative relevance of phosphorylation of the Thr17 residue of phospholamban is different at different levels of beta-adrenergic stimulation. Pflugers Arch 444, 801–809.[CrossRef][Medline]
Salas MA, Vila Petroff MG, Palomeque J, Aiello EA & Mattiazzi A (2001). Positive inotropic and negative lusitropic effect of angiotensin II: intracellular mechanisms and second messengers. J Mol Cell Cardiol 33, 1957–1971.[CrossRef][Medline]
Schouten
VJ (1990). Interval dependence of force and twitch duration in rat heart explained by Ca2+ pump inactivation in sarcoplasmic reticulum. J Physiol
431, 427–444.
Spurgeon HA, Stern MD, Baartz G, Raffaeli S, Hansford RG, Talo A et al. (1990). Simultaneous measurement of Ca2+, contraction, and potential in cardiac myocytes. Am J Physiol 258, H574–H586.[Medline]
Tokumitsu
H, Chijiwa
T, Hagiwara
M, Mizutani
A, Terasawa
M
&
Hidaka
H (1990). KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. J Biol Chem
265, 4315–4320.
Toyofuku
T, Curotto Kurzydlowski
K, Narayanan
N
&
MacLennan
DH (1994). Identification of Ser38 as the site in cardiac sarcoplasmic reticulum Ca2+-ATPase that is phosphorylated by Ca2+/calmodulin-dependent protein kinase. J Biol Chem
269, 26492–26496.
Tsien RW, Bean BP, Hess P, Lansman JB, Nilius B & Nowycky MC (1986). Mechanisms of calcium channel modulation by beta-adrenergic agents and dihydropyridine calcium agonists. J Mol Cell Cardiol 18, 691–710.[Medline]
Vila-Petroff
MG, Palomeque
J
&
Mattiazzi
AR (2003). Na+–Ca2+ exchange function underlying contraction frequency inotropy in the cat myocardium. J Physiol
550, 801–817.
Vittone L, Mundiña C, Chiappe de Cingolani C & Mattiazzi A (1990). cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts. Am J Physiol 258, H318–H325.[Medline]
Vittone
L, Mundiña-Weilenmann
C, Said
M
&
Mattiazzi
A (1998). Mechanisms involved in the acidosis enhancement of the isoproterenol induced phosphorylation of phospholamban in the intact heart. J Biol Chem
273, 9804–9811.
Wegener AD, Simmerman HKB, Lindemann JP & Jones LR (1989). Phospholamban phosphorylation in intact ventricles. Phosphorylation of serine 16 and threonine 17 in response to ß-adrenergic stimulation. J Biol Chem 261, 13333–13341.
Xu
A, Hawkins
C
&
Narayanan
N (1993). Phosphorylation and activation of the Ca2+-pumping ATPase of cardiac sarcoplasmic reticulum by Ca2+/calmodulin-dependent protein kinase. J Biol Chem
268, 8394–8397.
Xu A & Narayanan N (1999). Ca2+/calmodulin-dependent phosphorylation of the Ca2+-ATPase, uncoupled from phospholamban, stimulates Ca2+-pumping in native cardiac sarcoplasmic reticulum. Biochem Biophys Res Commun 258, 66–72.[CrossRef][Medline]
Xu
A
&
Narayanan
N (2000). Reversible inhibition of the calcium-pumping ATPase in native cardiac sarcoplasmic reticulum by a calmodulin-binding peptide. Evidence for calmodulin-dependent regulation of the V(max) of calcium transport. J Biol Chem
275, 4407–4416.
Zhao W, Uehara Y, Chu G, Song Q, Quian J et al. (2004). Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase in cardiac contractility. J Mol Cell Cardiol 37, 607–612.[CrossRef][Medline]
|
Acknowledgements |
|---|
This article has been cited by other articles:
|
|
 |
|
  A. A. Werdich, E. A. Lima, I. Dzhura, M. V. Singh, J. Li, M. E. Anderson, and F. J. Baudenbacher Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2352 - H2362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. MacQuaide, J. Dempster, and G. L. Smith Measurement and Modeling of Ca2+ Waves in Isolated Rabbit Ventricular Cardiomyocytes Biophys. J., October 1, 2007; 93(7): 2581 - 2595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Szentandrassy, M. R. Perez-Bido, E. Alonzo, N. Negretti, and S. C. O'Neill Protein kinase A is activated by the n-3 polyunsaturated fatty acid eicosapentaenoic acid in rat ventricular muscle J. Physiol., July 1, 2007; 582(1): 349 - 358. [Abstract] [Full Text] [PDF]
|
in A) similar to that induced by increasing isoprenaline from 0.3 to 300 nM (
) or Thr17 (•) residues. Results are expressed as means ±
S.E.M. of n
= 4–12 experiments; t
ms) with respect to 120 beats min–1 (A) or the absence of drug (B). *P < 0.05 with respect to 120 beats min–1 (A) or the absence of drug (B).
P < 0.05 with respect to the t